Sutro Biopharma, Inc.
- STRO
- NASDAQ
- Biotechnology
- Protein-Based Therapeutics
- Cancer/Autoimmune Drug Development
$10.94
Today −4.54%Quote Oct 16, 2026, 08:00 PM UTC
−29.33%over the last month
Max drawdown −35.7%From 1-month high −33.1%3 months −51.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$181.4M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$51.00
+366.2% from here
Floor
$10.05
8.2% below price
Where the price sits
20 analysts
Analyst range, low to high
$43.00$60.00
- Price $10.94
- Resistance $11.26
- Consensus $51.00
The price is right under resistance. Analysts' average target sits about 366% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about STROPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
128
Founded
2003